» Articles » PMID: 32174129

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

Overview
Specialties Oncology
Radiology
Date 2020 Mar 17
PMID 32174129
Citations 712
Authors
Affiliations
Soon will be listed here.
Abstract

Available information on CT features of the 2019 novel coronavirus disease (COVID-19) is scattered in different publications, and a cohesive literature review has yet to be compiled. This article includes a systematic literature search of PubMed, Embase (Elsevier), Google Scholar, and the World Health Organization database. Known features of COVID-19 on initial CT include bilateral multilobar ground-glass opacification (GGO) with a peripheral or posterior distribution, mainly in the lower lobes and less frequently within the right middle lobe. Atypical initial imaging presentation of consolidative opacities superimposed on GGO may be found in a smaller number of cases, mainly in the elderly population. Septal thickening, bronchiectasis, pleural thickening, and subpleural involvement are some of the less common findings, mainly in the later stages of the disease. Pleural effusion, pericardial effusion, lymphadenopathy, cavitation, CT halo sign, and pneumothorax are uncommon but may be seen with disease progression. Follow-up CT in the intermediate stage of disease shows an increase in the number and size of GGOs and progressive transformation of GGO into multifocal consolidative opacities, septal thickening, and development of a crazy paving pattern, with the greatest severity of CT findings visible around day 10 after the symptom onset. Acute respiratory distress syndrome is the most common indication for transferring patients with COVID-19 to the ICU and the major cause of death in this patient population. Imaging patterns corresponding to clinical improvement usually occur after week 2 of the disease and include gradual resolution of consolidative opacities and decrease in the number of lesions and involved lobes. This systematic review of current literature on COVID-19 provides insight into the initial and follow-up CT characteristics of the disease.

Citing Articles

Large Hemorrhagic Pericardial Effusion and Cardiac Tamponade Following BNT162b2 (BioNTech/Pfizer) Vaccine.

Nguyen H, Nguyen M, Olenik A Brown J Hosp Med. 2025; 1(4):39814.

PMID: 40046798 PMC: 11878855. DOI: 10.56305/001c.39814.


Association of Pulmonary Involvement at Baseline with Exercise Intolerance and Worse Physical Functioning 8 Months Following COVID-19 Pneumonia.

Uzel F, Peker Y, Atceken Z, Karatas F, Atasoy C, Caglayan B J Clin Med. 2025; 14(2.

PMID: 39860481 PMC: 11765862. DOI: 10.3390/jcm14020475.


Rates of PCR Positivity of Pleural Drainage Fluid in COVID-19 Patients: Is It Expected?.

Turut H, Ozcelik N, Cicek A, Tuluce K, Sevilgen G, Sakin M Life (Basel). 2025; 14(12.

PMID: 39768333 PMC: 11676780. DOI: 10.3390/life14121625.


Preliminary application of robot-assisted teleultrasound-guided interventional system.

Liu F, Qi E, Wang X, Wang Y, Gao Y, Yu X Abdom Radiol (NY). 2024; .

PMID: 39690280 DOI: 10.1007/s00261-024-04719-5.


Quantitative Chest CT Analysis: Three Different Approaches to Quantify the Burden of Viral Interstitial Pneumonia Using COVID-19 as a Paradigm.

Fanni S, Colligiani L, Volpi F, Novaria L, Tonerini M, Airoldi C J Clin Med. 2024; 13(23).

PMID: 39685766 PMC: 11642375. DOI: 10.3390/jcm13237308.